A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Items 701–800 of 1,003
Visceral Obesity without Insulin Resistance in Late-Onset Obesity Rats
Bains, R. K., Wells, S. E., Flavell, D., Fairhall, K. M., Strom, M., Tissier, P. L., & Robinson, I. C. A. F. (2004) · Endocrinology · doi:10.1210/en.2003-1608 · Cited by 44
Zhang, Y., Zhong, X., Gjoka, Z., Li, Y., Stochaj, W. R., Stahl, M., Kriz, R., Tobin, J. F., Erbe, D. V., & Suri, V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.004 · Cited by 44
The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors
Yuan, C., Jean, D. J. S., Liu, Q., Cai, L., Li, A., Han, N., Moniz, G. A., Askew, B. C., Hungate, R. W., Johansson, L., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.070 · Cited by 44
Hult, M., Shafqat, N., Elleby, B., Mitschke, D., Svensson, S., Forsgren, M., Barf, T. A., Vallgårda, J., Abrahmsén, L., & Oppermann, U. C. T. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.043 · Cited by 44
Sundbom, M., Kaiser, C., Björkstrand, E., Castro, V. M., Larsson, C., Selén, G., Nyhem, C. S., & James, S. R. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-3 · Cited by 44
“This is in accordance with the report of Masuzaki et al which describes transgenic mice overexpressing 11β HSD1 in adipose tissue with decreased adiponectin expression in mesenteric fat [4].”
BackgroundResultThe Role of Adipose Tissue in Insulin Resistance in Women of African Ancestry
Goedecke, J. H., Levitt, N. S., Evans, J., Ellman, N., Hume, D. J., Kotzé-Hörstmann, L. M., Tootla, M., Victor, H., & Keswell, D. (2013) · Journal of Obesity · doi:10.1155/2013/952916 · Cited by 44
“11HSD1 is of potential pathogenic importance in body fat distribution and insulin resistance, since transgenic mice overexpressing 11HSD1 selectively in adipose tissue have increased VAT accumulation and insulin resistance [40].”
BackgroundLack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue
Bujalska, I. J., Hewitt, K., Hauton, D., Lavery, G. G., Tomlinson, J., Walker, E. A., & Stewart, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1705 · Cited by 44
Nakano, S., Inada, Y., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Arai, N., Ebihara, K., Hosoda, K., Maruyama, K., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00340.2006 · Cited by 44
“Targeted overexpression of 11 -HSD1 in adipose tissue in mice results in visceral fat obesity, insulin resistance, and hypertension, suggesting that increased level of adipose 11 -HSD1 plays a critical role in metabolic derangements by providing local glucocorticoid excess within fat cells (29, 30).”
BackgroundSelf-citationAndersson, T., Simonyte, K., Andrew, R., Strand, M., Burén, J., Walker, B. R., Mattsson, C., & Olsson, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008475 · Cited by 37
“11bHSD1 knockout mice are protected from visceral fat accumulation when fed a high-fat diet [10], while selective over-expression of 11bHSD1 in adipose tissue results in abdominal obesity, insulin resistance, and hypertension [11,12].”
BackgroundAdrenal and gonadal function in obesity
Pasquali, R., Vicennati, V., & Gambineri, A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344053 · Cited by 44
Glucocorticoid therapy and the risk of equine laminitis
Cornelisse, C. J., & Robinson, N. E. (2011) · Equine Veterinary Education · doi:10.1111/j.2042-3292.2011.00320.x · Cited by 44
“…(Masuzaki et al. 2001; Paulmyer-Lacroix et al. 2002), which in turn is associated with an impaired local production of the vasodilator nitric oxide (NO) by endothelial cells (Masuzaki et al. 2001; Paulmyer-Lacroix et al. 2002; Steinberg and Baron 2002; Trovati and Anfossi 2002; Bakker et al. 2009).”
BackgroundMoreno‐Navarrete, J. M., & Fernández‐Real, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_3 · Cited by 44
Role of the Renin–Angiotensin– Aldosterone System in the Metabolic Syndrome
Engeli, S. (2006) · KARGER eBooks · doi:10.1159/000095324 · Cited by 44
Marcolongo, P., Piccirella, S., Senesi, S., Wunderlich, L., Gerin, I., Mandl, J., Fulceri, R., Bánhegyi, G., & Benedetti, A. (2007) · Endocrinology · doi:10.1210/en.2006-1472 · Cited by 44
The brain–adipose axis: A review of involvement of molecules
Shimizu, H., & Mori, M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047245 · Cited by 44
“This type 1 enzyme converts inactive cortisone into active cortisol, and its over-expression causes obesity (Masuzaki et al. 2001).”
BackgroundLow nephron number?a new cardiovascular risk factor in children?
Amann, K., Plank, C., & D�tsch, J. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1643-5 · Cited by 44
“, by an increase in cortisol synthesis in the adipose tissue (11bHSD 1) [32] or by an increase in sympathetic activity via elevated adipose tissue leptin synthesis [33].”
Background11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases
Fotsch, C. H., Askew, B. C., & Chen, J. J. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.3.289 · Cited by 44
“In another study, transgenic mice were generated that overexpressed rat 11βHSD1 in white adipose tissue [13].”
BackgroundBernardi, J. R., Ferreira, C. F., Senter, G., Krolow, R., de Aguiar, B. W., Portella, A. K., Kauer-Sant'Anna, M., Kapczinski, F., Dalmaz, C., Goldani, M. Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062031 · Cited by 43
“The resulting positive energy balance, especially in an animal known to have a maladaptive response to stress [5], with amplification of glucocorticoid action, is probably playing an important role in the development of the central abdominal obesity [38] that we described in this group.”
BackgroundPapargyri, P., Zapanti, E. D., Salakos, N., Papargyris, L., Bargiota, Α., & Mastorakos, G. P. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1543585 · Cited by 43
Praveenkumar, E., Gurrapu, N., Kolluri, P. K., Yerragunta, V., Kunduru, B. R., & Subhashini, N. J. P. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103056 · Cited by 43
Swine Disease Models for Optimal Vascular Engineering
Sturek, M. S., Alloosh, M., & Sellke, F. W. (2020) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082919-053009 · Cited by 43
Lloyd, D. J., Helmering, J., Cordover, D., Bowsman, M., Chen, M., Hale, C., Fordstrom, P., Zhou, M., Wang, M., Kaufman, S. A., et al. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01034.x · Cited by 39
Association between dairy product intake and abdominal obesity in Azorean adolescents
Abreu, S., Santos, R., Moreira, C. M. M., Vale, S. M. C. G., Santos, P. C., Soares‐Miranda, L., Marques, A. I., Mota, J. A. P. S., & Moreira, P. A. M. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.32 · Cited by 43
11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents
Webster, S. P., & Pallin, T. D. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.12.1407 · Cited by 43
“Transgenic mice with adipose-selective overexpression of 11 β -HSD1 are obese and develop many of the features of the metabolic syndrome, including glucose intolerance, insulin resistance, dyslipidaemia and hypertension [10,11] .”
Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone
Duplomb, L., Lee, Y., Wang, M.-Y., Park, B. H., Takaishi, K., Agarwal, A. K., & Unger, R. H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.160 · Cited by 43
Fatty Acid Metabolism and Vascular Disease
Semenkovich, C. F. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.12.004 · Cited by 43
Jain, S., Li, Y., Patil, S., & Kumar, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0621-5 · Cited by 43
“This hypothesis has recently been confirmed in transgenic mice in which 11-β HSD-1 was overexpressed in adipose tissue [20].”
BackgroundAzilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats
Zhao, M., Li, Y., Wang, J., Ebihara, K., Rong, X., Hosoda, K., Tomita, T., & Nakao, K. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01471.x · Cited by 42
“The adipose enzyme, 11β-HSD1, which locally converts inactive glucocorticoids into bioactive forms [18], plays an important role in the development of visceral obesity and its associated metabolic disturbances [19–22].”
BackgroundDiscovery of adamantane ethers as inhibitors of 11β-HSD-1: Synthesis and biological evaluation
Patel, J. R., Shuai, Q., Dinges, J., Winn, M., Pliushchev, M. A., Fung, S., Monzon, K., Chiou, W. J. H., Wang, J., Pan, L., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.074 · Cited by 42
Fructose promotes the differentiation of 3T3‐L1 adipocytes and accelerates lipid metabolism
Legeza, B., Balázs, Z., & Odermatt, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.014 · Cited by 42
“Importantly, overexpression of 11b-HSD1 specifically in adipose tissue caused metabolic syndrome in mice [13].”
BackgroundThe metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.1.39 · Cited by 42
Tissue‐specific dysregulation of cortisol metabolism in equine laminitis
Johnson, P. J., Ganjam, V. K., Slight, S. H., Kreeger, J. M., & Messer, N. T. (2004) · Equine Veterinary Journal · doi:10.2746/0425164044864750 · Cited by 42
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41
“Tissue-specific overproduction of 11βHSD1 within adipose tissue or skeletal muscle increases local glucocorticoids and similarly induces insulin resistance [39, 48].”
Background11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome
Joharapurkar, A. A., Dhanesha, N., Shah, G. B., Kharul, R. K., & Jain, M. R. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70903-9 · Cited by 41
“On the other hand, upregulation of 11b-HSD1 expression selectively in adipose tissue leads to a model of metabolic syndrome in mice [33].”
Adipose Tissue Lipokines: Recent Progress and Future Directions
Li, V. L., Kim, J. T., & Long, J. Z. (2020) · Diabetes · doi:10.2337/dbi20-0012 · Cited by 41
“Even adipose-produced lipophilic hormones such as cortisol were established to be locally acting and functionally dissociated from the circulating, adrenal gland–derived pools (7).”
BackgroundYoum, J., Park, K., Uchida, Y., Chan, A., Mauro, T. M., Holleran, W. M., & Elias, P. M. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12083 · Cited by 36
Gibbs, J. P., Emery, M. G., McCaffery, I., Smith, B., Gibbs, M. A., Akrami, A., Rossi, J. M., Paweletz, K. L., Gastonguay, M. R., Bautista, E., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010374470 · Cited by 41
“Finally, transgenic mice with targeted adipose-specific overexpression of the rat 11β-HSD1 had increased adipose levels of corticosterone with accompanying diet-induced visceral obesity, insulin resistance, hyperlipidemia, and hyperphagia.(22) In contrast, selective overexpression of 11β-HSD1 in liver only caused mild…”
BackgroundConstantinopoulos, P., Michalaki, M. A., Kottorou, A. E., Habeos, I. G., Psyrogiannis, A. I., Kalfarentzos, F., & Kyriazopoulou, V. E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0626 · Cited by 41
Andersson, T., Söderström, I., Šimonytė, K., & Olsson, T. (2010) · Obesity · doi:10.1038/oby.2009.294 · Cited by 41
“The association between perirenal 11βHSD1 activity and LPL expression in the OVX animals, as well as lower levels of LPL expression in perirenal adipose tissue from the OVX+E2 animals are in line with previous studies showing that LPL is upregulated by cortisol and downregulated by estrogen, and also upregulated in ad…”
BackgroundResultSteroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
“[68] Chader GJ, Rust N, Burton RM, Westphal U.”
BackgroundInfluentialDo, T. T. H., Garcia, M., Dalle, H., Dorothée, G., Moldes, M., Fève, B., & Buyse, M. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.08.010 · Cited by 41
Effects of resistin expression on glucose metabolism and hepatic insulin resistance
Li, F., He, J., Li, Z., Luo, Z., Yan, L., & Yan, L. (2009) · Endocrine · doi:10.1007/s12020-009-9148-4 · Cited by 41
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
Aslanidi, G., Kroutov, V., Philipsberg, G. A., Lamb, K. E., Campbell‐Thompson, M., Walter, G. A., Kurenov, S. N., Aguirre, J. I., Keller, P., Hankenson, K. D., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00248.2007 · Cited by 41
“Adipose-specific overexpression of 11 -HSD1 produces a phenotype analogous to the metabolic syndrome (with central obesity, insulin resistance, and dyslipidemia) (28).”
Transgenic animal models for the study of adipose tissue biology
Blüher, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.006 · Cited by 41
Garcia, R. A., Search, D. J., Lupisella, J. A., Ostrowski, J., Guan, B., Chen, J., Yang, W.-P., Truong, A. B., He, A., Zhang, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053192 · Cited by 40
“In the mouse, selective overexpression of 11bHSD1 in adipose tissue yields a distinctive phenotype of visceral obesity with many features of the metabolic syndrome [13].”
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 40
“Transgenic mice selectively overexpressing 11β-HSD1 in the adipose tissue develop metabolic syndrome including insulin-resistant diabetes, hyperlipidemia, hypertension, and visceral obesity [49, 50], whereas hepatic overexpression of 11β-HSD1 caused metabolic syndrome without obesity [51].”
Background11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice
Doig, C. L., Fletcher, R. S., Morgan, S., McCabe, E. L., Larner, D. P., Tomlinson, J., Stewart, P. M., Philp, A., & Lavery, G. G. (2017) · Endocrinology · doi:10.1210/en.2016-1722 · Cited by 40
“other than that 11b-HSD1 KO mice have elevated core temperature, and adipose-overexpressing transgenic mice have suppressed UCP1 mRNA expression (25, 37).”
BackgroundSagmeister, M. S., TAYLOR, A. E. R., Fenton, A., Wall, N. A., Chanouzas, D., Nightingale, P., Ferro, C. J., Arlt, W., Cockwell, P., Hardy, R., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13889 · Cited by 40
Perinatal programming of metabolic diseases: The role of glucocorticoids
Facchi, J. C., de Lima, T. A. L., de Oliveira, L. R., Costermani, H. D. O., Miranda, G. D. S., & de Oliveira, J. C. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154047 · Cited by 41
Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders
Lin, Y., Zhang, Z., Wang, S., Cai, J., & Guo, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09586-1 · Cited by 41
The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction
Federico, M., de la Fuente, S., Palomeque, J., & Sheu, S. (2021) · The Journal of Physiology · doi:10.1113/jp279376 · Cited by 40
Oda, S., Ashida, K., Uchiyama, M., Sakamoto, S., Hasuzawa, N., Nagayama, A., Wang, L., Nagata, H., Sakamoto, R., Kishimoto, J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab450 · Cited by 40
Cassano, A., White, J. R., Penraat, K. A., Wilson, C. D., Rasmussen, S., & Karatsoreos, I. N. (2012) · Europe PMC (PubMed Central) · Cited by 40
Synthesis of Potent and Orally Efficacious 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor HSD-016
Wan, Z.-K., Chenail, E., Li, H.-Q., Kendall, C., Wang, Y., Gingras, S., Xiang, J., Massefski, W. W., Mansour, T., & Saiah, E. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200958a · Cited by 35
Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors
Yang, H., Shen, Y., Chen, J., Jiang, Q., Leng, Y., & Shen, J. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.06.005 · Cited by 40
“In contrast, animals with elevated adipose 11b-HSD1 expression develop metabolic syndrome-like phenotypes [5].”
BackgroundCrystal Structures of 11β-Hydroxysteroid Dehydrogenase Type 1 and Their Use in Drug Discovery
THOMAS, M. P., & Potter, B. V. L. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.10.282 · Cited by 40
Effect of Nutrient Ingestion on Total-Body and Splanchnic Cortisol Production in Humans
Basu, R., Singh, R., Basu, A., Johnson, C. M., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1335 · Cited by 37
“Conversely, inhibition of this pathway in mice appears to enhance insulin action and protect against diet-induced obesity, diabetes, and hypertension (3,4).”
BackgroundEffects of age and diet on glucose and insulin dynamics in the horse
Rapson, J., Schott, H. C., Nielsen, B. D., McCutcheon, L. J., Harris, P. A., & Geor, R. J. (2018) · Equine Veterinary Journal · doi:10.1111/evj.12812 · Cited by 40
Cleasby, M., Livingstone, D., Nyirenda, M., Seckl, & Walker, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480129 · Cited by 34
“However, it is widely supposed that effects on hepatic metabolism are mediated by factors released from adipose tissue that are altered by thiazolidinediones, such as resistin (43), free fatty acids (44) or glucocorticoids ( 45 ).”
BackgroundSelf-citationPharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients
Freemark, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021033 · Cited by 40
Postnatal maternal separation modifies the response to an obesogenic diet in adulthood
Paternain, L., Martisova, E., Milagro, F. I., Ramírez, M. J., Martínez, J. A., & Campión, J. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009043 · Cited by 39
“Glucocorticoids are widely mentioned as triggering both lipolysis and adipogenesis, depending on the concentration, duration and type of glucocorticoid investigated, as well as the experimental model used (Kershaw et al., 2006; Masuzaki et al., 2001; Xu et al., 2009).”
Melis, D., Rossi, A., Pivonello, R., Salerno, M., Balivo, F., Spadarella, S., Muscogiuri, G., Casa, R. D., Formisano, P., Andria, G., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0301-2 · Cited by 39
“11β-HSD1 activity in adipose tissue in obese rats and in some but not all studies of obese humans causes visceral obesity and its metabolic consequences [3].”
Chu, L., Yang, L., Lin, L., Wei, J., Wang, N., Xu, M. J., Qiao, G., & Zheng, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.082 · Cited by 39
Mundt, S. S., Solly, K. J., Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.367 · Cited by 39
Discovery of cyclicsulfonamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors
Kim, S. H., Ramu, R., Kwon, S. W., Lee, S.-H., Kim, C. H., Kang, S. K., Rhee, S. D., Bae, M. A., Ahn, S. H., Ha, D. C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.035 · Cited by 39
Effects of Nutraceuticals on Genetic Expressions
Mishra, S., Singh, R. B., Dwivedi, S. P., Meester, F. D., Rybár, R., Pella, D., Fedačko, J., & Juneja, L. R. (2009) · The Open Nutraceuticals Journal · doi:10.2174/1876396000902010070 · Cited by 39
“in may inherit risk and may have interaction of nature and nurture [1-6].”
BackgroundInfluentialAlterations of Cortisol Metabolism in Human Disorders
White, P. C. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485508 · Cited by 39
Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice
Ferguson, D., Hutson, I., Tycksen, E., Pietka, T., Bauerle, K. T., & Harris, C. A. (2019) · Endocrinology · doi:10.1210/endocr/bqz010 · Cited by 39
Hunter−Killer Peptide (HKP) for Targeted Therapy
Ellerby, H. M., Bredesen, D. E., Fujimura, S., & John, V. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800495u · Cited by 39
Tomlinson, J. W., Crabtree, N., Clark, P. M. S., Holder, G., Toogood, A. A., Shackleton, C. H. L., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021894 · Cited by 38
Molnár, Á., Kövesdi, A., Szücs, N., Tóth, M., Igaz, P., Rácz, K., & Patócs, A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13022 · Cited by 38
Will treating diabetes with 11β-HSD1 inhibitors affect the HPA axis?
Harno, E., & White, A. E. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.004 · Cited by 38
Wang, W., Song, X., Gao, Z., Zhao, H., Wang, X., Liu, M., & Jia, L. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.182 · Cited by 38
Shibata, S., & Fujita, T. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.018 · Cited by 39
Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity
London, E., & Castonguay, T. W. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.02.012 · Cited by 38
“7fold, respectively) [18].”
BackgroundInfluentialShapiro, A. M., Matheny, M. E., Zhang, Y., Tümer, N., Cheng, K., Rogrigues, E., Zolotukhin, S., & Scarpace, P. J. (2007) · Diabetes · doi:10.2337/db07-0863 · Cited by 38
“Elevated 11β-HSD1 activity in adipose tissue leads to increased glucocorticoid receptor activation and hence promotes obesity (32; 33).”
BackgroundReduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys
Wiegand, S., Richardt, A., Remer, T., Wudy, S. A., Tomlinson, J. W., Hughes, B., Grüters, A., Stewart, P. M., Strasburger, C. J., & Quinkler, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0193 · Cited by 37
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
Clarke, S. A., Eng, P. C., Comninos, A. N., Lazarus, K., Choudhury, S., Tsang, C., Meeran, K. M., Tan, T., Dhillo, W. S., & Abbara, A. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae016 · Cited by 38
Pierotti, S., Gandini, L., Lenzi, A., & Isidori, A. M. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.018 · Cited by 37
Chen, W., Wang, L., Liu, H., Long, L., & Li, S. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00268.x · Cited by 37
McInnes, K. J., Andersson, T. C., Šimonytė, K., Söderström, I., Mattsson, C., Seckl, J. R., & Olsson, T. (2012) · Menopause · doi:10.1097/gme.0b013e318258aad7 · Cited by 32
Self-citationAubry, E. M., & Odermatt, A. (2009) · Endocrinology · doi:10.1210/en.2008-1618 · Cited by 37
“org Endocrinology, June 2009, 150(6):2700–2708”
BackgroundInfluentialGumy, C., Thurnbichler, C., Aubry, E. M., Balázs, Z., Pfisterer, P. H., Baumgartner, L., Stuppner, H., Odermatt, A., & Rollinger, J. M. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.01.009 · Cited by 37
Vuorinen, A., Nashev, L. G., Odermatt, A., Rollinger, J. M., & Schuster, D. (2013) · Molecular Informatics · doi:10.1002/minf.201300063 · Cited by 38
Nobre, J. L., Lisboa, P. C., Santos-Silva, A. P., Lima, N. S., Manhães, A. C., Nogueira-Neto, J. F., Cabanelas, A., Pazos-Moura, C. C., de Moura, E. G., & Oliveira, E. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0172 · Cited by 37
“Experimental studies (Masuzaki et al. 2001) have shown higher 11b-HSD-1 gene expression in adipose tissue associated with features of metabolic syndrome such as increased waist circumference and IR.”
BackgroundRelationship of milk intake and physical activity to abdominal obesity among adolescents
Abreu, S., Santos, R., Moreira, C. M. M., Santos, P. C., Vale, S. M. C. G., Soares‐Miranda, L., Autran, R., Mota, J. A. P. S., & Moreira, P. A. M. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00130.x · Cited by 37
“Visceral adipose tissue has greater amounts of 11-b-hidroxysteroid dehydrogenase type 1 (45), which is over-expressed in vitro in those with central adiposity (46).”
BackgroundLi, X., Lindquist, S., Chen, R., Myrnäs, T., Angsten, G., Olsson, T., & Hernell, O. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803470 · Cited by 37
Jornayvaz, F. R., Selz, R., Tappy, L., & Theintz, G. E. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.003 · Cited by 37
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Anderson, J. L., Carlquist, J. F., Roberts, W. L., Horne, B. D., May, H. T., Schwarz, E. L., Pasquali, M., Nielson, R., Kushnir, M. M., Rockwood, A. L., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.10.014 · Cited by 37
Löffler, M. G., Bilban, M., Reimers, M., Waldhäusl, W. K., & Stulnig, T. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093831 · Cited by 37
“Hsd11b1 is particularly expressed in human and rodent liver and adipose tissue (Bujalska et al., 2002), and increased expression has been linked to development of diabetes and the metabolic syndrome (Aoki et al., 2001; Masuzaki et al., 2001).”
BackgroundGu, S., Ripp, S. L., Prough, R. A., & Geoghegan, T. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.722 · Cited by 37
“It is considered an amplifier of glucocorticoid action and has recently been shown to be the primary determinant of visceral obesity (Masuzaki et al., 2001).”
BackgroundMetabolic syndrome X is common in South Asians, but why and how?
Das, U. N. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00826-2 · Cited by 37
Brief review: Glucocorticoid excretion in obesity
Müssig, K., Remer, T., & Maser-Gluth, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.008 · Cited by 36
and the PREDICT Investigator Group, Stevens, A., Clayton, P., Tatò, L., Yoo, H. W., Rodriguez-Arnao, M. D., Skorodok, J., Ambler, G. R., Zignani, M., Zieschang, J., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.14 · Cited by 35
New advances in models and strategies for developing anti-obesity drugs
Kim, G. W., Lin, J. E., Blomain, E. S., & Waldman, S. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.792804 · Cited by 37
“Transgenic mice with increased 11b-HSD1 activity exhibit obese symptoms, including excess visceral fat, insulin resistance and dyslipidemia [137].”
BackgroundPatel, H., Dhangar, K., Sonawane, Y. A., Surana, S. J., Karpoormath, R. V., Thapliyal, N. B., Shaikh, M. S., Noolvi, M. N., & Jagtap, R. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.08.003 · Cited by 36
“These compounds are examples of the so-called selectivity cliffs, because they show a closely related structural similarity but large changes in biological activity (Medina-Franco, 2012).”
BackgroundZoppini, G., Targher, G., Venturi, C., Zamboni, C., & Muggeo, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02154.x · Cited by 30
A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation
Park, J. S., Bae, S. J., Choi, S., Son, Y. H., Park, S. B., Rhee, S. D., Kim, H. Y., Jung, W. H., Kang, S. K., Ahn, J. H., et al. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0177 · Cited by 36
“…2014 Society for Endocrinology DOI: 10.1530/JME-13-0177 Printed in Great Britain as central obesity, glucose intolerance, and insulin resistance (Masuzaki et al. 2001), but those tissues fromHsd11b1 knock-out mice showed a reduction in high-fat dietinduced obesity with improved insulin…”
BackgroundInfluentialHale, C., Véniant, M. M., Wang, Z., Chen, M., McCormick, J., Cupples, R. L., Hickman, D., Min, X., Sudom, A. M., Xu, H., et al. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00603.x · Cited by 36
“Although the plasma level of corticosterone in these mice did not change, the corticosterone level in the portal vein increased (7).”
Background
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.